|
|||||
|
|
Assessment of mutational profile of Japanese lung adenocarcinoma patients by multitarget assays: A prospective,single‐institute study |
|
| Authors: | Masakuni Serizawa PhD Yasuhiro Koh MD Hirotsugu Kenmotsu MD Mitsuhiro Isaka MD Haruyasu Murakami MD Hiroaki Akamatsu MD Keita Mori MSc Masato Abe Isamu Hayashi Tetsuhiko Taira MD Tomohiro Maniwa MD Toshiaki Takahashi MD Masahiro Endo MD Takashi Nakajima MD Yasuhisa Ohde MD Nobuyuki Yamamoto MD |
| Affiliation: | 1. Division of Thoracic Oncology, Shizuoka Cancer Center, Shizuoka, Japan;2. Drug Discovery and Development Division, Shizuoka Cancer Center Research Institute, Shizuoka, Japan;3. Division of Thoracic Surgery, Shizuoka Cancer Center, Shizuoka, Japan;4. Third Department of Internal Medicine, Wakayama Medical University, Kimiidera, Wakayama, Japan;5. Clinical Trial Coordination Office, Shizuoka Cancer Center, Shizuoka, Japan;6. Division of Pathology, Shizuoka Cancer Center, Shizuoka, Japan;7. Division of Diagnostic Radiology, Shizuoka Cancer Center, Shizuoka, Japan |
| Abstract: | |
| Keywords: | lung adenocarcinoma driver mutation multimutational profiling molecular‐targeted therapeutics personalized cancer medicine |